STOCK TITAN

[Form 4] Nuvalent, Inc. Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4

Nuvalent (NUVL) reported an insider transaction by its Chief Financial Officer. On 10/15/2025, the CFO exercised 1,683 stock options at $18.93 per share and sold 1,683 Class A shares at a weighted average price of $85.57, with individual sales ranging from $85.00 to $85.69. The trades were made under a Rule 10b5-1 plan adopted on December 12, 2024.

Following these transactions, the CFO beneficially owned 61,734 Class A shares directly and 28,979 derivative securities (stock options). The filing lists transaction codes M (option exercise) and S (sale).

Nuvalent (NUVL) ha riportato una operazione insider da parte del suo Direttore Finanziario. Il 15/10/2025, il CFO ha esercitato 1.683 stock option al prezzo di $18.93 per azione e ha venduto 1.683 azioni di Classe A ad un prezzo medio ponderato di $85.57, con vendite singole comprese tra $85.00 e $85.69. Le operazioni sono state effettuate secondo un piano Rule 10b5-1 adottato il 12 dicembre 2024.

A seguito di queste transazioni, il CFO detiene in modo vantaggioso 61.734 azioni di Classe A direttamente e 28.979 titoli derivati (stock option). La richiesta riporta i codici di transazione M (esercizio opzione) e S (vendita).

Nuvalent (NUVL) informó una operación interna por parte de su Director Financiero. El 15/10/2025, el CFO ejerció 1,683 opciones sobre acciones a un precio de $18.93 por acción y vendió 1,683 acciones Clase A a un precio medio ponderado de $85.57, con ventas individuales que oscilaban entre $85.00 y $85.69. Las operaciones se realizaron bajo un plan Rule 10b5-1 adoptado el 12 de diciembre de 2024.

Tras estas transacciones, el CFO posee de forma beneficiosa 61,734 acciones Clase A directamente y 28,979 valores derivados (opciones sobre acciones). La presentación lista los códigos de transacción M (ejercicio de opción) y S (venta).

Nuvalent (NUVL)가 최고재무책임자(CFO)에 의한 내부자 거래를 보고했습니다. 2025년 10월 15일에 CFO가 1,683주 옵션$18.93에 행사하고 1,683주 클래스 A 주식를 가중 평균가 $85.57로 매도했으며, 개별 매도가 $85.00에서 $85.69 사이였습니다. 거래는 Rule 10b5-1 계획에 따라 2024년 12월 12일에 채택되었습니다.

이 거래 이후 CFO는 61,734주 클래스 A 주식를 직접 보유하고 있으며 28,979개의 파생 증권 (주식 옵션)도 보유하고 있습니다. 공시는 거래 코드 M (옵션 행사)와 S (매도)를 목록화합니다.

Nuvalent (NUVL) a fait état d'une transaction d'initié par son directeur financier. Le 15/10/2025, le CFO a exercé 1 683 options d'achat à $18,93 par action et a vendu 1 683 actions de Classe A à un prix moyen pondéré de $85,57, avec des ventes unitaires allant de $85,00 à $85,69. Les transactions ont été effectuées dans le cadre d'un plan Rule 10b5-1 adopté le 12 décembre 2024.

Suite à ces transactions, le CFO détenait de manière bénéficiaire 61 734 actions de Classe A directement et 28 979 titres dérivés (options d'achat). Le dépôt énumère les codes de transaction M (exercice d'option) et S (vente).

Nuvalent (NUVL) meldete eine Insider-Transaktion durch seinen Chief Financial Officer. Am 15. Oktober 2025 hob der CFO 1.683 Aktienoptionen zu je $18,93 pro Aktie aus und verkaufte 1.683 Class-A-Aktien zu einem gewichteten Durchschnittspreis von $85,57, wobei einzelne Verkäufe zwischen $85,00 und $85,69 lagen. Die Trades wurden im Rahmen eines Rule 10b5-1-Plans durchgeführt, der am 12. Dezember 2024 beschlossen wurde.

Nach diesen Transaktionen besaß der CFO direkt 61.734 Class-A-Aktien und darüber hinaus 28.979 derivative Wertpapiere (Aktienoptionen). In der Einreichung werden die Transaktionscodes M ( Optionsausübung) und S (Verkauf) aufgeführt.

نيفوالنت (NUVL) أبلغت عن صفقة داخلية قام بها المدير المالي التنفيذي. في 15 أكتوبر 2025 قام المدير المالي التنفيذي بممارسة 1,683 خياراً للأسهم بسعر $18.93 للسهم وبيع 1,683 سهماً من فئة A بسعر متوسط مرجح قدره $85.57، وكانت المبيعات الفردية بين $85.00 و $85.69. تمت هذه التداولات وفقاً لخطة Rule 10b5-1 المعتمدة في 12 ديسمبر 2024.

وبعد هذه المعاملات، امتلك المدير المالي التنفيذي بشكلٍ مستفيد 61,734 سهماً من فئة A مباشرة و 28,979 ورقة مشتقة (خيار الأسهم). وتذكر الإيداع رموز المعاملة M (تمرين الخيار) و S (بيع).

Nuvalent (NUVL) 报告了首席财务官的内部人交易。于 2025年10月15日,CFO 行使了 1,683 份股票期权,价格为每股 $18.93,并以加权平均价格 $85.57 出售了 1,683 股 Class A 股,单笔交易价格区间为 $85.00$85.69。交易是在于 2024年12月12日通过的 Rule 10b5-1 计划下进行的。

交易完成后,CFO 直接拥有 61,734 股 Class A 股,并持有 28,979 项派生证券(股票期权)。备案列出交易代码 M(期权行使)和 S(出售)。

Positive
  • None.
Negative
  • None.

Insights

Analyzing...

Nuvalent (NUVL) ha riportato una operazione insider da parte del suo Direttore Finanziario. Il 15/10/2025, il CFO ha esercitato 1.683 stock option al prezzo di $18.93 per azione e ha venduto 1.683 azioni di Classe A ad un prezzo medio ponderato di $85.57, con vendite singole comprese tra $85.00 e $85.69. Le operazioni sono state effettuate secondo un piano Rule 10b5-1 adottato il 12 dicembre 2024.

A seguito di queste transazioni, il CFO detiene in modo vantaggioso 61.734 azioni di Classe A direttamente e 28.979 titoli derivati (stock option). La richiesta riporta i codici di transazione M (esercizio opzione) e S (vendita).

Nuvalent (NUVL) informó una operación interna por parte de su Director Financiero. El 15/10/2025, el CFO ejerció 1,683 opciones sobre acciones a un precio de $18.93 por acción y vendió 1,683 acciones Clase A a un precio medio ponderado de $85.57, con ventas individuales que oscilaban entre $85.00 y $85.69. Las operaciones se realizaron bajo un plan Rule 10b5-1 adoptado el 12 de diciembre de 2024.

Tras estas transacciones, el CFO posee de forma beneficiosa 61,734 acciones Clase A directamente y 28,979 valores derivados (opciones sobre acciones). La presentación lista los códigos de transacción M (ejercicio de opción) y S (venta).

Nuvalent (NUVL)가 최고재무책임자(CFO)에 의한 내부자 거래를 보고했습니다. 2025년 10월 15일에 CFO가 1,683주 옵션$18.93에 행사하고 1,683주 클래스 A 주식를 가중 평균가 $85.57로 매도했으며, 개별 매도가 $85.00에서 $85.69 사이였습니다. 거래는 Rule 10b5-1 계획에 따라 2024년 12월 12일에 채택되었습니다.

이 거래 이후 CFO는 61,734주 클래스 A 주식를 직접 보유하고 있으며 28,979개의 파생 증권 (주식 옵션)도 보유하고 있습니다. 공시는 거래 코드 M (옵션 행사)와 S (매도)를 목록화합니다.

Nuvalent (NUVL) a fait état d'une transaction d'initié par son directeur financier. Le 15/10/2025, le CFO a exercé 1 683 options d'achat à $18,93 par action et a vendu 1 683 actions de Classe A à un prix moyen pondéré de $85,57, avec des ventes unitaires allant de $85,00 à $85,69. Les transactions ont été effectuées dans le cadre d'un plan Rule 10b5-1 adopté le 12 décembre 2024.

Suite à ces transactions, le CFO détenait de manière bénéficiaire 61 734 actions de Classe A directement et 28 979 titres dérivés (options d'achat). Le dépôt énumère les codes de transaction M (exercice d'option) et S (vente).

Nuvalent (NUVL) meldete eine Insider-Transaktion durch seinen Chief Financial Officer. Am 15. Oktober 2025 hob der CFO 1.683 Aktienoptionen zu je $18,93 pro Aktie aus und verkaufte 1.683 Class-A-Aktien zu einem gewichteten Durchschnittspreis von $85,57, wobei einzelne Verkäufe zwischen $85,00 und $85,69 lagen. Die Trades wurden im Rahmen eines Rule 10b5-1-Plans durchgeführt, der am 12. Dezember 2024 beschlossen wurde.

Nach diesen Transaktionen besaß der CFO direkt 61.734 Class-A-Aktien und darüber hinaus 28.979 derivative Wertpapiere (Aktienoptionen). In der Einreichung werden die Transaktionscodes M ( Optionsausübung) und S (Verkauf) aufgeführt.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Balcom Alexandra

(Last) (First) (Middle)
C/O NUVALENT, INC.
ONE BROADWAY, 14TH FLOOR

(Street)
CAMBRIDGE MA 02142

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Nuvalent, Inc. [ NUVL ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
10/15/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Class A Common Stock 10/15/2025 M(1) 1,683 A $18.93 63,417 D
Class A Common Stock 10/15/2025 S(1) 1,683 D $85.57(2) 61,734 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $18.93 10/15/2025 M(1) 1,683 (3) 01/04/2032 Class A Common Stock 1,683 $0.00 28,979 D
Explanation of Responses:
1. These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2024.
2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.69, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price.
3. The shares underlying this option vest as follows: 25% of the shares vested on January 4, 2023, and the remainder have vested or shall vest over the three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.
/s/ Nathan N. McConarty, attorney-in-fact 10/17/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Nuvalent (NUVL) disclose in this Form 4?

The CFO exercised 1,683 stock options at $18.93 and sold 1,683 shares at a weighted average price of $85.57 on 10/15/2025.

Were the NUVL trades made under a Rule 10b5-1 plan?

Yes. The transactions were effected under a Rule 10b5-1 trading plan adopted on December 12, 2024.

What price range were the NUVL shares sold at?

Sales occurred in multiple trades at prices ranging from $85.00 to $85.69, inclusive.

How many NUVL shares does the CFO own after the transactions?

The CFO beneficially owned 61,734 Class A shares directly after the reported transactions.

How many stock options remain after the transactions?

The filing shows 28,979 derivative securities (stock options) beneficially owned following the transactions.

What do the transaction codes M and S indicate?

M denotes an option exercise; S denotes an open market sale.
Nuvalent, Inc.

NASDAQ:NUVL

NUVL Rankings

NUVL Latest News

NUVL Latest SEC Filings

NUVL Stock Data

6.52B
63.38M
2.84%
109.13%
7.61%
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE